(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CBMD

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

CBMD

ST13

US500000088636842

Class

41

Filing

88636842

Registration

6660174

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

10/12/2023

Trademark type

Combined

Nice classes

41

Filing date

09/30/2019

Registration date

03/01/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/01/2022

Last transaction

10/12/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

09/30/2019

First use in commerce

08/14/2021

Drawing code

3

Owner type

03

Owner location

Carson City, NV, US

Examiner

ADORNO SANTOS, LUZ M.

Law office

M20

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the letters "CBMD", which are within an oblong.

Holders and representatives

Holders

CBMD, Inc.

Representatives

Marc E. Hankin HANKIN PATENT LAW, APC

Technical classification

Nice Classes

Class 41

Vienna Codes

No Vienna codes available.

Goods and services

Class 41

Education servicesproviding on-line seminarsworkshopsclasses in the field of healthwellness improvement by use of dietary supplementstopical creams; Education servicesproviding seminarsworkshopsclasses in the fields of healthwellness improvement by use of dietary supplementstopical creams; Educational servicesproviding educational speakers in the field of the efficacy of dietary and topical supplementscannabidiol and industrial hemp supplements

Publications

History of USPTO decisions and trademark events.

31 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/12/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/12/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/12/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

03/01/2022

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/25/2022

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/22/2022

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/04/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

12/17/2021

IUAF

USE AMENDMENT FILED

11/24/2021

EISU

TEAS STATEMENT OF USE RECEIVED

11/24/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/26/2021

EX1G

SOU EXTENSION 1 GRANTED

05/24/2021

EXT1

SOU EXTENSION 1 FILED

05/24/2021

EEXT

SOU TEAS EXTENSION RECEIVED

05/24/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

11/24/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/29/2020

PUBO

PUBLISHED FOR OPPOSITION

09/29/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/09/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/24/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

08/24/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/24/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

08/24/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/24/2020

DOCK

ASSIGNED TO EXAMINER

08/18/2020

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

10/22/2019

DOCK

ASSIGNED TO EXAMINER

10/20/2019

ALIE

ASSIGNED TO LIE

10/16/2019

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

10/10/2019

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

10/05/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/04/2019

NWAP

NEW APPLICATION ENTERED

10/03/2019

Continuous trademark protection

Get notified about every new filing that threatens CBMD or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.